128 results
8-K
EX-99.1
NAOV
NanoVibronix Inc
16 May 24
NanoVibronix Issues Letter to Stockholders
4:05pm
therapies, which we believe enable healthcare providers to treat patients in need and fill a void in the market, which has the potential to increase … products; (x) legislative or regulatory reform impacting the healthcare system in the U.S. or in foreign jurisdictions; (xi) our reliance on single
8-K
EX-99.1
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
and commercializing our distinct and effective therapies, which we believe enable healthcare providers to treat patients in need, fill a void in the market and have … ) legislative or regulatory reform impacting the healthcare system in the U.S. or in foreign jurisdictions; (xi) our reliance on single suppliers
8-K
EX-99.1
NAOV
NanoVibronix Inc
28 Mar 24
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
9:09am
to successfully obtain and maintain intellectual property protection covering our products; (x) legislative or regulatory reform impacting the healthcare system
8-K
EX-99.1
ukg8wbtp12hs5dc2af
28 Nov 23
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
9:00am
8-K
EX-99.1
xbgzgqs
21 Nov 23
Other Events
8:30am
8-K
EX-99.1
7j8al5rjjuadq 4v9q
14 Nov 23
NanoVibronix Issues Letter to Shareholders
12:00am
8-K
EX-99.1
2lu1q6akd6ee7zk
7 Nov 23
Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand
8:30am
8-K
EX-99.1
ji4mn1 lf
27 Sep 23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:00am
424B3
2lop59pnie8jy1
21 Sep 23
Prospectus supplement
10:27am
8-K
EX-99.1
rfy04ln1n p7dle
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
EX-99.1
cv6kq
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
EX-99.1
fqjfv yhc1rv5
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am
8-K
EX-99.1
7aovngnm6niehpvb
29 Aug 23
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
prv9e3 3cjp
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
EX-99.1
xn4swdle vl143
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm
8-K
zfnlsspf
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm